Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice

Journal of Neurosurgery

Volumn 124, Issue 6, 2016, Pages 1693-1702

  Fujimoto, Masashi ^a   Shiba, Masato ^a   Kawakita, Fumihiro ^a   Liu, Lei ^a   Shimojo, Naoshi ^a,b   Imanaka Yoshida, Kyoko ^a,b   Yoshida, Toshimichi ^a,b   Suzuki, Hidenori ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Pathology and Matrix Biology ^*  (Japan)

Author keywords

Blood brain barrier disruption; Brain edema; Early brain injury; Knockout mice; Subarachnoid hemorrhage; Tenascin C; Vascular disorders

Indexed keywords

EVANS BLUE; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE BUFFERED SALINE; PROTEIN ZO1; TENASCIN; MMP9 PROTEIN, MOUSE; TJP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN EDEMA; BRAIN WATER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME DEGRADATION; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; DEFICIENCY; FEMALE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN EDEMA; CAPILLARY PERMEABILITY; FEMALE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; RANDOM ALLOCATION; SUBARACHNOID HEMORRHAGE; TENASCIN; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84975230838     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2015.4.JNS15484     Document Type: Article

References (36)

1. Altay O, Suzuki H, Hasegawa Y, Caner B, Krafft PR, Fujii M, et al: Isofurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke 43:2513-2516, 2012
2. Ayer RE, Sugawara T, Chen W, Tong W, Zhang JH: Melato-nin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res 44:197-204, 2008
3. Caner B, Hou J, Altay O, Fuj M II, Zhang JH: Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. J Neurochem 123 (Suppl 2):12-21, 2012
4. Cho A, Graves J, Reidy MA: Mitogen-activated protein ki-nases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532, 2000
5. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA: Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 33:1225-1232, 2002
6. Eroglu C: The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J Cell Commun Signal 3:167-176, 2009
7. Feiler S, Plesnila N, Thal SC, Zausinger S, Schöller K: Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 32:289-295, 2011
8. Fujimoto M, Suzuki H, Shiba M, Shimojo N, Imanaka-Yoshida K, Yoshida T, et al: Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol Dis 55:104-109, 2013
9. Golledge J, Clancy P, Maguire J, Lincz L, Koblar S: The role of tenascin C in cardiovascular disease. Cardiovasc Res 92:19-28, 2011
10. Hamada K, Miura Y, Toma N, Miyamoto K, Imanaka-Yoshi-da K, Matsushima S, et al: Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats. Transl Stroke Res 5:595-603, 2014
11. Horstmann S, Su Y, Koziol J, Meyding-Lamadé U, Nagel S, Wagner S: MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci 251:82-86, 2006
12. Ilunga K, Nishiura R, Inada H, El-Karef A, Imanaka-Yoshida K, Sakakura T, et al: Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. Int J Exp Pathol 85:373-379, 2004
13. Imanaka-Yoshida K: Tenascin-C in cardiovascular tissue remodeling: from development to infammation and repair. Circ J 76:2513-2520, 2012
14. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T: Tenascin-C upregulates matrix me-talloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer 105:53-60, 2003
15. Kuriyama N, Duarte S, Hamada T, Busuttil RW, Coito AJ: Tenascin-C: a novel mediator of hepatic ischemia and reper-fusion injury. Hepatology 54:2125-2136, 2011
16. Mehta V, Russin J, Spirtos A, He S, Adamczyk P, Amar AP, et al: Matrix metalloproteinases in cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res Int 2013:943761, 2013
17. Midwood KS, Orend G: The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3:287-310, 2009
18. Nag S, Manias JL, Stewart DJ: Pathology and new play-ers in the pathogenesis of brain edema. Acta Neuropathol 118:197-217, 2009
19. Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pat-tinson KT: Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109:315-329, 2012
20. Sabri M, Lass E, Macdonald RL: Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res Treat 2013:394036, 2013
21. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S: Mice develop normally without tenascin. Genes Dev 6:1821-1831, 1992
22. Sarrafzadeh A, Copin JC, Bengualid DJ, Turck N, Vajkoczy P, Bijlenga P, et al: Matrix metalloproteinase-9 concentration in the cerebral extracellular fuid of patients during the acute phase of aneurysmal subarachnoid hemorrhage. Neurol Res 34:455-461, 2012
23. Sehba FA, Mostafa G, Knopman J, Friedrich V Jr, Bederson JB: Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101:633-640, 2004
24. Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, Taki W, Suzuki H: Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats. Transl Stroke Res 5:238-247, 2014
25. Shiba M, Suzuki H, Fujimoto M, Shimojo N, Imanaka-Yoshi-da K, Yoshida T, et al: Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis 46:172-179, 2012
26. Suarez JI, Tarr RW, Selman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387-396, 2006
27. Sugawara T, Ayer R, Jadhav V, Zhang JH: A new grading system evaluating bleeding scale in flament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167:327-334, 2008
28. Suzuki H, Ayer R, Sugawara T, Chen W, Sozen T, Hasegawa Y, et al: Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats. Crit Care Med 38:612-618, 2010
29. Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH: Mecha-nisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 41:1783-1790, 2010
30. Suzuki H, Kanamaru K, Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, et al: Cerebrospinal fuid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 23:310-317, 2011
31. Suzuki H, Kanamaru K, Suzuki Y, Aimi Y, Matsubara N, Araki T, et al: Tenascin-C is induced in cerebral vasospasm after subarachnoid hemorrhage in rats and humans: a pilot study. Neurol Res 32:179-184, 2010
32. Suzuki H, Kinoshita N, Imanaka-Yoshida K, Yoshida T, Taki W: Cerebrospinal fuid tenascin-C increases preceding the development of chronic shunt-dependent hydrocephalus after subarachnoid hemorrhage. Stroke 39:1610-1612, 2008
33. van Gijn J, Kerr RS, Rinkel GJ: Subarachnoid haemorrhage. Lancet 369:306-318, 2007
34. Wallner K, Li C, Shah PK, Wu KJ, Schwartz SM, Sharif BG: EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 24:1416-1421, 2004
35. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T: Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch 435:496-500, 1999
36. Zappaterra MW, LaMantia AS, Walsh CA, Lehtinen MK: Isolation of cerebrospinal fuid from rodent embryos for use with dissected cerebral cortical explants. J Vis Exp 73:e50333, 2013